1. Ahrén B, Arkhammar P, Berggren P-O, Nilsson T. Galanin inhibits glucose-stimulated insulin release by a mechanism involving hyperpolarization and lowering of cytoplasmic free Ca2+ concentration. Biochem Biophys Res Commun 1986;140:1059–1063.

2. Amiranoff B, Lorinet AM, Laburthe M. Galanin receptor in the rat pancreatic beta-cell line Rin m5F—molecular characterization by chemical cross-linking. J Biol Chem 1989;264:20714–20717.

3. Amiranoff B, Lorinet AM, Lagny-Pourmir I, Laburthe M. Mechanism of galanin-inhibited insulin release. Occurrence of a pertussis-toxin-sensitive inhibition of adenylate cyclase. Eur J Biochem 1988;177:147–152.

4. Amiranoff B, Servin AL, Rouyer-Fessard C, Couvineau A, Tatemoto K, Laburthe M. Galanin receptors in a hamster pancreatic b-cell tumor: identification and molecular characterization. Endocrinology 1987;121:284–289.

5. Bartfai T, Bedecs K, Land T, et al. M-15—high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord. Proc Natl Acad Sci USA 1991;88:10961–10965.

6. Bartfai T, Fisone G, Langel Ü. Galanin and galanin antagonists—molecular and biochemical perspectives. Trends Pharmacol Sci 1992;13:312–317.

6a. Bartfai T, Langel Ü, Bedecs K, Andell S, Land T, Gregersen S, Ahrén B, Girotti P, Consolo S, Corwin R, Crawley J, Xu XJ, Wiesenfeld-Hallin Z, Hökfelt T. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci USA 1993;90:11287–11291.

7. Bauer FE, Ginsberg L, Venetikou M, MacKay DJ, Burrin JM, Bloom SR. Growth hormone release in man induced by galanin, a new hypothalamic peptide. Lancet 1986;2:192–194.

8. Bauer FE, Hacker GW, Terenghi G, Adrian TE, Polak JM, Bloom SR. Localization and molecular forms of galanin in human adrenals: elevated levels in pheochromocytomas. J Clin Endocrinol Metab 1986;63:1372–1378.

9. Bauer FE, Zintel A, Kenny MJ, Calder D, Ghatei MA, Bloom SR. Inhibitory effect of galanin on postprandial gastrointestinal motility and gut hormone release in humans. Gastroenterology 1989; 97:260–264.

10. Bedecs K, Langel Ü, Bartfai T, Wiesenfeld-Hallin Z. Galanin receptors and their second messengers in the lumbar dorsal spinal cord. Acta Physiol Scand 1992;144:213–220.

11. Bersani M, Thim L, Rasmussen TN, Holst JJ. Galanin and galanin extended at the N-terminus with seven and nine amino acids are produced in and secreted from the porcine adrenal medulla in almost equal amounts. Endocrinology 1991;129:2693–2698.

12. Ch'ng JLC, Christofides ND, Anand P, et al. Distribution of galanin immunoreactivity in the central nervous system and the responses of galanin-containing neuronal pathways to injury. Neuroscience 1985;16:343–354.

13. Chan-Palay V. Neurons with galanin innervate cholinergic cells in the human basal forebrain and galanin and acetylcholine coexist. Brain Res Bull 1988;21:465–472.

14. Chan-Palay V. Hyperinnervation of surviving neurons of the human basal nucleus of Meynert by galanin in dementias of Alzheimer's and Parkinson's disease. Alzheimer's Dis 1990;51:253–255.

15. Chen YH, Couvineau A, Laburthe M, Amiranoff B. Solubilization and molecular characterization of active galanin receptors from rat brain. Biochemistry 1992;31:2415–2422.

16. Consolo S, Bertorelli R, Girotti P, et al. Pertussis toxin-sensitive G-protein mediates galanin's inhibition of scopolamine-evoked acetylcholine release in vivo and carbachol-stimulated phosphoinositide turnover in rat ventral hippocampus. Neurosci Lett 1991; 126:29–32.

17. Cortés R, Villar MJ, Verhofstad A, Hökfelt T. Effects of central nervous system lesions on the expression of galanin—a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci USA 1990;87:7742–7746.

18. Crawley J, Austin MC, Fiske SM, et al. Activity of centrally administered galanin fragments on stimulation of feeding behaviour and on galanin receptor binding in the rat hypothalamus. J Neurosci 1990;10:3695–3700.

19. Crawley JN, Robinson JK, Langel Ü, Bartfai T. Galanin receptor antagonist-M40 and antagonist-C7 block galanin-induced feeding. Brain Res 1993;600:268–272.

20. de Weille J, Schmid-Antomarchi H, Fosset M, Lazdunski M. ATP-sensitive K+-channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci USA 1988;85:1312–1316.

21. Dunne MJ, Bullett MJ, Li GD, Wollheim CB, Petersen OH. Galanin activates nucleotide-dependent K+ channels in insulin-secreting cells via a pertussis toxin-sensitive G-protein. EMBO J 1989;8:413–417.

22. Dunning BE, Karlsson S, Ahrén B. Contribution of galanin to stress-induced impairment of insulin secretion in swimming mice. Acta Physiol Scand 1991;143:145–152.

23. Dutar P, Lamour Y, Nicoll RA. Galanin blocks the slow cholinergic EPSP in CA1 pyramidal neurons from ventral hippocampus. Eur J Pharmacol 1989;164:355–360.

24. Evans H, Shine J. Human galanin: molecular cloning reveals a unique structure. Endocrinology 1991;129:1682–1684.

25. Everitt BJ, Meister B, Hökfelt T, et al. The hypothalamic arcuate nucleus-median eminence complex: immunohistochemistry of transmitters, peptides and DARPP-32 with special reference to coexistence in dopamine neurons. Brain Res Rev 1986;11:97–155.

26. Fisone G, Bartfai T, Nilsson S, Hökfelt T. Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus. Brain Res 1991;568:279–284.

27. Fisone G, Berthold M, Bedecs K, et al. N-Terminal galanin-(1-16) fragment is an agonist at the hippocampal galanin receptor. Proc Natl Acad Sci USA 1989;86:9588–9591.

28. Fisone G, Wu CF, Consolo S, et al. Galanin inhibits acetylcholine release in the ventral hippocampus of the rat: histochemical, autoradiographic, in vivo, and in vitro studies. Proc Natl Acad Sci USA 1987;84:7339–7343.

29. Fuxe K, Ögren S-O, Jansson A, Cintra A, Hårfstrand A, Agnati LF. Intraventricular injections of galanin reduces 5-HT metabolism in the ventral limbic cortex, the hippocampal formation and the fronto-parietal cortex of the male rat. Acta Physiol Scand 1988; 133:579–581.

30. Gabriel SM, Rivkin A, Mercado J. The galanin antagonist, M-15, inhibits growth hormone release in rats. Peptides 1993;14:633–636.

31. Gallwitz B, Schmidt WE, Schwarzhoff R, Creutzfeldt W. Galanin—structural requirements for binding and signal transduction in Rin m5F insulinoma cells. Biochem Biophys Res Commun 1990; 172:268–275.

32. Ghigo E, Maccario M, Arvat E, et al. Interactions of galanin and arginine on growth hormone, prolactin, and insulin secretion in man. Metabolism 1992;41:85–89.

33. Giustina A, Girelli A, Bodini C, et al. Comparative effect of porcine and rat galanin on growth hormone secretion in normal adult men. Horm Metab Res 1992;24:90–91.

34. Givens BS, Olton DS, Crawley JN. Galanin in the medial septal area impairs working memory. Brain Res 1992;582:71–77.

35. Gregersen S, Hermansen K, Lindskog S, et al. Galanin-induced inhibition of insulin secretion from rat islets: effects of rat and pig galanin and galanin fragments and analogues. Eur J Pharmacol 1991;203:111–114.

36. Gregersen S, Lindskog S, Land T, Langel Ü, Bartfai T, Ahren B. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist-M35. Eur J Pharmacol 1993;232:35–39.

37. Holets VR, Hökfelt T, Rökaeus A, Terenius L, Goldstein M. Locus coeruleus neurons in the rat containing neuropeptide Y, tyrosine hydroxylase or galanin and their efferent projections to the spinal cord, cerebral cortex and hypothalamus. Neuroscience 1988; 24:893–906.

38. Homaidan FR, Sharp GWG, Nowak LM. Galanin inhibits a dihydropyridine-sensitive Ca2+ current in the Rin m5F cell line. Proc Natl Acad Sci USA 1991;88:8744–8748.

39. Hulting A-L, Meister B, Grimelius L, Wersäll J, Änggård A, Hökfelt T. Production of a galanin-like peptide by a human pituitary adenoma: immunohistochemical evidence. Acta Physiol Scand 1990;137:561–562.

40. Kaplan LM, Hooi SC, Abraczinkas DR, et al. Neuroendocrine regulation of galanin gene expression. In: Hökfelt T, Bartfai T, Jacobowitz D, Ottoson D, eds. Galanin: a new multifunctional peptide in the neuro-endocrine system. London: McMillan Press, 1991;43–65.

41. Kordower JH, Le HK, Mufson EJ. Galanin immunoreactivity in the primate central nervous system. J Comp Neurol 1992;319:479–500.

42. Köhler C, Ericson H, Watanabe T, et al. Galanin immunoreactivity in hypothalamic histamine neurons: further evidence for multiple chemical messengers in the tuberomammillary nucleus. J Comp Neurol 1986;250:58–64.

43. Lamour Y, Senut MC, Dutar P, Bassant MH. Neuropeptides and septo-hippocampal neurons: electrophysiological effects and distributions of immunoreactivity. Peptides 1988;9:1351–1359.

44. Land T, Langel Ü, Bartfai T. Hypothalamic degradation of galanin(1-29) and galanin(1-16): identification and characterization of the peptidolytic products. Brain Res 1991;558:245–250.

45. Land T, Langel Ü, Fisone G, Bedecs K, Bartfai T. Assay for galanin receptor. Methods Neurosci 1991;5:225–234.

46. Land T, Langel Ü, Löw M, Berthold M, Undén A, Bartfai T. Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor. Int J Peptide Protein Res 1991;38:267–272.

47. Laporta C, Bianchi R, Sozzani S, Bartfai T, Consolo S. Galanin reduces PDBu-induced protein phosphorylation in rat ventral hippocampus. FEBS Lett 1992;300:46–48.

48. Leibowitz SF, Kim T. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion. Brain Res 1992; 599:148–152.

49. Lindskog S, Ahrén B, Land T, Langel Ü, Bartfai T. The novel high affinity antagonist galantide blocks the galanin mediated inhibition of glucose-induced insulin secretion. Eur J Pharmacol 1992; 210:183–188.

50. Malin DH, Novy BJ, Lettbrown AE, et al. Galanin attenuates retention of one-trial reward learning. Life Sci 1992;50:939–944.

51. Mastropaolo J, Nadi NS, Ostrowski NL, Crawley JN. Galanin antagonizes acetylcholine on a memory task in basal forebrain-lesioned rats. Proc Natl Acad Sci USA 1988;85:9841–5.

52. McDonald TJ, Dupre J, Tatemoto K, Greenberg GR, Radziuk J, Mutt V. Galanin inhibits insulin secretion and induces hyperglycemia in dogs. Diabetes 1985;34:192–196.

53. Meister B, Hökfelt T. Peptide- and transmitter-containing neurons in the mediobasal hypothalamus and their relation to GABA-ergic systems: possible roles in control of prolactin and growth hormone secretion. Synapse 1988;2:585–605.

54. Melander T, Hökfelt T, Rökaeus Å. Distribution of galanin-like immunoreactivity in the rat central nervous system. J Comp Neurol 1986;248:475–517.

55. Melander T, Hökfelt T, Rökaeus Å, et al. Coexistence of galanin-like immunoreactivity with catecholamines, 5-hydroxytryptamine, GABA and neuropeptides in the rat CNS. J Neurosci 1986;6:3640–3654.

56. Melander T, Hökfelt T, Rökaeus Å, Fahrenkrug J, Tatemoto K, Mutt V. Distribution of galanin-like immunoreactivity in the gastro-intestinal tract of several mammalian species. Cell Tissue Res 1985;239:253–270.

57. Merchentaler ILFJ, Negro-Vilar A. Anatomy and physiology of central galanin containing pathways. Prog Neurobiol 1993;40:711–769.

58. Nilsson T, Arkhammar P, Rorsman P, Berggren PO. Suppression of insulin release by galanin and somatostatin is mediated by a G-protein. An effect involving repolarization and reduction in cytoplasmic free Ca2+ concentration. J Biol Chem 1989;264:973–980.

59. Nishibori M, Oishi R, Itoh Y, Saeki K. Galanin inhibits noradrenaline-induced accumulation of cyclic AMP in the rat cerebral cortex. J Neurochem 1988;51:1953–1955.

60. Ottlecz A, Snyder GD, McCann SM. Regulatory role of galanin in control of hypothalamic–anterior pituitary function. Proc Natl Acad Sci USA 1988;85:9861–9865.

61. Palazzi E, Felinska S, Zambelli M, Fisone G, Bartfai T, Consolo S. Galanin reduces carbachol stimulation of phosphoinositide turnover in rat ventral hippocampus by lowering Ca2+ influx through voltage-sensitive Ca2+-channels. J Neurochem 1991;56:739–747.

62. Rossowski WJ, Rossowski TM, Zacharia S, Ertan A, Coy DH. Galanin binding sites in rat gastric and jejunal smooth muscle membrane preparation. Peptides 1990;11:333–338.

63. Senut MC, Menetrey D, Lamour Y. Cholinergic and peptidergic projections from the medial septum and the nucleus of the diagonal band of Broca to dorsal hippocampus, cingulate cortex and olfactory bulb: a combined wheatgerm agglutinin–apohorseradish peroxidase–gold immunohistochemical study. Neuroscience 1989; 30:385–403.

64. Seutin V, Verbanck P, Massotte L, Dresse A. Galanin decreases the activity of locus coeruleus neurons in vitro. Eur J Pharmacol 1989;164:373–376.

65. Sharp GW, Le M, Brustel Y, et al. Galanin can inhibit insulin release by a mechanism other than membrane hyperpolarization or inhibition of adenylate cyclase. J Biol Chem 1989;264:7302–7309.

66. Skofitsch G, Jacobowitz DM. Immunohistochemical mapping of galanin-like neurons in the rat central nervous system. Peptides 1985;6:509–546.

67. Skofitsch G, Jacobowitz DM. Quantitative distribution of galanin-like immunoreactivity in the rat central nervous system. Peptides 1986;7:609–613.

68. Sundström E, Melander T. Effects of galanin on 5-HT neurons in the rat CNS. Eur J Pharmacol 1988;146:327–329.

69. Tatemoto K, Rökaeus Å, Jörnvall H, McDonald TJ, Mutt V. Galanin—a novel biologically active peptide from porcine intestine. FEBS Lett 1983;164:124–128.

70. Verge VMK, Xu XJ, Langel Ü, Hökfelt T, Wiesenfeld-Hallin Z, Bartfai T. Evidence for endogenous inhibition of autotomy by galanin in the rat after sciatic nerve section—demonstrated by chronic intrathecal infusion of a high affinity galanin receptor antagonist. Neurosci Lett 1993;149:193–197.

71. Villar MJ, Cortés R, Theodorsson E, et al. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 1989;33:587–604.

72. Vrontakis ME, Schroedter IC, Cosby H, Friesen HG. Expression and secretion of galanin during pregnancy in the rat. Endocrinology 1992;130:458–464.

73. Vrontakis ME, Torsello A, Friesen HG. Galanin. J Endocrinol Invest 1991;14:785–794.

74. Wiesenfeld-Hallin Z, Villar MJ, Hökfelt T. Intrathecal galanin at low doses increases spinal reflex excitability in rats more to thermal than mechanical stimuli. Exp Brain Res 1988;71:663–666.

75. Wiesenfeld-Hallin Z, Xu XJ, Hughes J, Horwell DC, Hökfelt T. PD134308, a selective antagonist of cholecystokinin type-B receptor, enhances the analgesic effect of morphine and synergistically interacts with intrathecal galanin to depress spinal nociceptive reflexes. Proc Natl Acad Sci USA 1990;87:7105–7109.

76. Wynick D, Smith DM, Ghatei M, et al. Characterization of a high-affinity galanin receptor in the rat anterior pituitary: absence of biological effect and reduced membrane binding of the antagonist M15 differentiate it from brain/gut receptor. Proc Natl Acad Sci USA 1993;90:4231–4235.

77. Yanaihara N, Mochizuki T, Iguchi K, et al. Structure–function relationships of galanin. In: Hökfelt T, Bartfai T, Jacobowitz D, Ottoson D, eds. Galanin: a new multifunctional peptide in the neuro-endocrine system. London: McMillan Press, 1991;185–196.

78. Zini S, Roisin MP, Langel Ü, Bartfai T, Benari Y. Galanin reduces release of endogenous excitatory amino acids in the rat hippocampus. Eur J Pharmacol Mol Pharmacol 1993;245:1–7.

79. Ögren S-O, Hökfelt T, Kask K, Langel Ü, Bartfai T. The galanin antagonist M 35 facilitates acquisition in the Morris swim maze. Neuroscience 1992;51:1–5.